MILESTONE SCIENTIFIC INC.
About MILESTONE SCIENTIFIC INC.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2014
- $2.6M
- Net income
- -$5.7M
- Total assets
- $7.8M
- Market cap
- $36.6M
- Gross margin
- 71.4%
- Operating margin
- -63.5%
- Net margin
- -63.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $9.0M
- Cost of revenue
- $2.6M
- Gross profit
- $6.4M
- Operating expenses
- $12.1M
- Operating income
- -$5.7M
- Net income
- -$5.7M
- EPS (basic)
- $-0.07
- EPS (diluted)
- $-0.07
Balance sheet
- Total assets
- $7.8M
- Current assets
- $7.5M
- Total liabilities
- $5.0M
- Current liabilities
- $4.1M
- Shareholders’ equity
- $2.8M
Cash flow
- Operating cash flow
- -$2.9M
- Investing cash flow
- -$15.1K
- Financing cash flow
- $786.3K
- Net cash flow
- -$2.1M
Statements via Polygon.io (SEC filings)
- Market cap
- $36.6M
- EPS (diluted)
- $-0.07
- Shares outstanding
- 96.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 3, 1995
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $5.7M in FY2014.
- Revenue declined 13% from FY2021 to FY2025.
- Gross margin of 71.4%, net margin -63.8%.
- Trading 64% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MILESTONE SCIENTIFIC INC..
Write a review
News about MILESTONE SCIENTIFIC INC.
News & sentiment via Polygon.io
